DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20190729

Association of patent ductus arteriosus (PDA) with prematurity and low birth weight neonates

Gh Rasool Wani, Nazir Ahmad Parray, Mohd Rafiq Lone, Nisar Ahmad Ganie, Anwar Hussain, Junaid Ul Islam, Syed Muneeb Mohammad, Syed Muneeb Mohammad

Abstract


Background: Patent ductus arteriosus (PDA) is a major morbidity encountered in preterm neonates, especially in babies less than 28 weeks gestation or 1000g. It may close spontaneously in preterm neonates; however, failure to close spontaneously in preterm neonates results in significant mortality and morbidity in them.

Methods: This prospective study was conducted in a tertiary care hospital in north India over a period of one year. The study cohort consisted of preterm, newborn babies admitted in the hospital with gestational age less than 37weeks and birth weight <2500g.

Results: In this study total number of patients admitted during the study were 2930. Out of these preterm low birth weight neonates were 432. Among preterm low birth weight neonates admitted, 132 neonates were excluded as per exclusion criteria. Patent ductus arteriosus was detected in 56 among the 300 neonates giving an overall incidence of patent ductus arteriosus 18.6%, the incidence of patent ductus arteriosus was 56.2% for neonates weighing less than 1000gm, 24.7% for neonates weighing between 1000-1499g, 11.6% for neonates weighing between 1500-1999g and 5.6% for the neonates weighing between 2000-2499g.

Conclusions: Thus, incidence of patent ductus arteriosus was inversely proportional to gestational age and birth. Data also suggest that immaturity is the major determinant of the persistent patency of ductus arteriosus.


Keywords


Patent ductus arteriosus, Preterm neonates, Screening

Full Text:

PDF

References


Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873-82.

Gittenberger-de Groot AC, van Ertbruggen I, Moulaert AJ, Harinck E. The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr. 1980;96(1):88-93.

Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973;51:220-5.

Leonhardt A, Glaser A, Wegmann M, Schranz D, Seyberth H, Nusing R. Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol. 2003;138:655-9.

Sasi A, Deorari A. Patent ductus arteriosus in preterm infants. Indian Pediatr. 2011;(48):301-7.

Gersony WM, Peckham GJ, Ellison RC, Meittinen OS, Nadas AS. Effect of indomethacin in premature infants with patent ductusarteriosus: result of national collaborative study. J Pediatr. 1983;102:895-905.

Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants >1000gms. Am J Perinatal. 2008;25:661-6.

Clyman RI. PDA in preterm neonates. Avery's Diseases of newborn. 8th ed. WB Saunders; 2003:816-826.

Clyman RI, Walch N. Regulation of ductus arteriosus by nitric oxide: Role of gestation oxygen tension and Vasavasorum. Pediatrics Res. 1998;43:633-44.

Kajino H, Chen YQ, Seidner SR, Waleh N, Mauray F, Roman C, et al. Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling. Am J Physiol Regulatory Integrative Comparative Physiol. 2001;281(1):R291-301.

Wechsler SB, Wenovsky G. Cardiac disorders in Cloherty JP manual on neonatal care. 6th ed; 2008:388-435.

Ellison RC, Peckham GJ, Lang P, Talner NS, Lerer TJ, Lin L, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics. 1983;71(3):364-72.

Bersten D. Patent ductusarteriosus. In: Nelson Textbook of Pediatrics. 2004;18:1510-1512.

Evan N, Lyser P. Assessment of Ductus arteriosus shunt in preterm infant supported by mechanical ventilation. J Pediatrics. 1992;125:771-5.

Walther FJ, Kim DH, Ebrahimi M, Siassi B. Pulsed Doppler measurement of left ventricular output as early predictor of symptomatic patent ductus arteriosus in very preterm infants. Neonatol. 1989;56(3):121-8.

Johnson GL, Breart GL, Gewitz MH, Brenner JI, Lang P, Dooley KJ, et al. Echocardiographic characteristics of premature infants with patent ductus arteriosus. Pediatrics. 1983;72(6):864-71.

Kitterman JA, Edmunds Jr LH, Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent Ductus arteriosus in premature infant-incidence, relation to pulmonary diseases and management. N England J Medicine 1972;287:473-7.

Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics. 1976;57(3):347-51.

Hammoud MS, Elsori HA, Hanafi EA, Shalabi AA, Fouda IA, Devarajan LV. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait. Saudi Med J. 2003;24(9):982-5.

Afiune JY, Singer JM. Echocardiographic postnatal progression in preterm neonates with PDA. J Pediatr. 2005;81(6):454-60.

Silverman NH, Lewis AB, Heymann MA, Rudolph AM. Echocardiographic assessment of ductus arteriosus shunt in premature infants. Circulation. 1974;50(4):821-5.

Moss AJ, Eummanouides G, Duffie ER. Closure of the ductus arteriosus in the newborn infant. Pediatr. 1963;32:25-30.

McGrath RL, McGuinness GA, Way GL, Wolfe RR, Nora JJ, Simmons MA. The silent ductus arteriosus. J Pediatr. 1978;93(1):110-3.

Behman RE, Jacob J, Gluck L, DiSessa T, Edwards D, Kulovich M, et al. The contribution of PDA in the neonate with severe RDS. J Pediatr. 1980;96(1):79-87.

Yeh TF, Can I. Pharmacological closure of PDA. In: Yeh TF, ed. Neonatal therapeutics. Chicago CV Mosby and year Book; 1991:123-138.